Table 1 Summary of clinical and histopathological data.

From: miRNA profiles of canine cutaneous mast cell tumours with early nodal metastasis and evaluation as potential biomarkers

 

Breed

Sex

Age (years)

Tumor location

Size (cm)

Grade

Lymph node statuse

Patnaik

Kiupel

1

American Staffordshire Terriera,d

Male

6

Trunk

1

II

Low

HN1

2

Bernese

Female

4

Limb

2.5

II

Low

HN2

3

Boxer

Male

8

Limb

2.2

II

Low

HN2

4

Dachshund

Female

9

Trunk

0.8

II

Low

HN0

5

Dogoa,b

Male

6

Limb

2

II

Low

HN2

6

English settera,b

Female

6

Trunk

3

II

Low

HN2

7

English settera,c,d

Female

11

Trunk

5

II

Low

HN3

8

Italian pointera,b

Male

5.5

Trunk

4

II

Low

HN1

9

Jack Russella,b

Male

13

Head

5

II

High

HN2

10

Labrador

Male

1

Head

1

I

Low

HN0

11

Labrador d

Male

10

Scrotum

2

II

Low

HN0

12

Labrador

Male

9

Trunk

0.6

II

Low

HN2

13

Labrador

Female

6

Trunk

3.5

II

Low

HN2

14

Mixed breeda,b,c

Female

11

Trunk

3

II

Low

HN0

15

Mixed breeda,b

Female

6

Trunk

4

II

Low

HN2

16

Mixed breeda,b

Male

11

Limb

3

III

High

HN2

17

Mixed breeda,c,d

Female

8

Limb

3

III

High

18

Mixed breedc

Male

12

Neck

7

II

Low

HN3

19

Pug

Male

3.5

Head

1

II

Low

HN2

20

Tosa inu

Male

4

Trunk

3

II

Low

HN2

21

Weimaraner

Male

7

trunk

2

II

Low

HN2

  1. aMCT samples sequenced using NGS.
  2. bHealthy margins sequenced using NGS.
  3. c$amples in which miRNAs selected for the RT-qPCR validation step were not detected.
  4. dSamples for which healthy margins were not collected.
  5. eClassification system proposed by Weishaar et al.7. HN histological node, NGS next-generation sequencing.